-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexaria Bioscience Corp. Announces Positive Interim Results from Phase 1b Study of DehydraTECH-GLP-1, Demonstrating Significant Reduction in Side Effects Compared to Rybelsus®

Reuters·07/28/2025 13:25:19

Please log in to view news